Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAVE: Tenofovir vs Abacavir Substitution for HIV Lipoatrophy
NCT00647946Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Feb 2003; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00647946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647946.